NOV (NOV) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
9 Apr, 2026Executive summary
Annual meeting scheduled for May 20, 2026, to elect nine directors, ratify Ernst & Young LLP as independent auditors for 2026, and approve executive compensation on an advisory basis.
Board recommends voting FOR all proposals; record date for voting is March 25, 2026.
Proxy materials are available online, with options for electronic or printed delivery; voting can be done online, by phone, or by mail.
Voting matters and shareholder proposals
Proposals include election of nine directors for a one-year term, ratification of auditors, and advisory approval of executive compensation.
Majority vote required for director election in uncontested elections; majority of shares present required for auditor ratification and say-on-pay.
Shareholder proposals for the 2027 meeting must be submitted by December 10, 2026.
Board of directors and corporate governance
Board consists of nine members with diverse backgrounds in energy, finance, technology, and governance.
Committees include Audit, Compensation, and Nominating/Corporate Governance, all composed of independent directors.
Lead Director role provides independent oversight; annual review of director independence and board composition.
Board values diversity and reviews director commitment annually.
Latest events from NOV
- Q4 2025 revenue up 5% to $2.28B, strong cash flow, and mixed segment trends amid market headwinds.NOV
Q4 20259 Jul 2026 - Q3 revenue and net income rose, with record backlog and strong offshore demand.NOV
Q3 20249 Jul 2026 - Q2 2025 saw sequential revenue growth, margin pressure, and strong digital contract wins.NOV
Q2 20258 Jul 2026 - Q3 2025 saw lower earnings but record bookings and strong free cash flow amid industry headwinds.NOV
Q3 20258 Jul 2026 - Q1 2026 revenue and profit declined due to Middle East disruptions; outlook remains cautious.NOV
Q1 202629 Apr 2026 - Votes sought for nine directors, auditor ratification, and executive pay approval.NOV
Proxy filing9 Apr 2026 - Q2 2024 revenue up 6% to $2.22B, with record backlog and higher shareholder returns.NOV
Q2 20242 Feb 2026 - Adjusted EBITDA and cash flow rose despite lower revenue, with strong capital returns and backlog.NOV
Q1 202519 Jan 2026 - 2024 delivered strong growth, cash flow, and backlog; 2025 outlook is flat revenue, higher margins.NOV
Q4 20249 Dec 2025